These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33817624)

  • 41. The optimal gestation for pertussis vaccination during pregnancy: a prospective cohort study.
    Naidu MA; Muljadi R; Davies-Tuck ML; Wallace EM; Giles ML
    Am J Obstet Gynecol; 2016 Aug; 215(2):237.e1-6. PubMed ID: 26968625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration.
    Healy CM; Rench MA; Swaim LS; Smith EO; Sangi-Haghpeykar H; Mathis MH; Martin MD; Baker CJ
    JAMA; 2018 Oct; 320(14):1464-1470. PubMed ID: 30304426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.
    Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Gonen R; Bamberger E
    Vaccine; 2014 Oct; 32(44):5787-93. PubMed ID: 25173476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.
    Halperin BA; Morris A; Mackinnon-Cameron D; Mutch J; Langley JM; McNeil SA; Macdougall D; Halperin SA
    Clin Infect Dis; 2011 Nov; 53(9):885-92. PubMed ID: 21946190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women.
    Huygen K; Caboré RN; Maertens K; Van Damme P; Leuridan E
    Vaccine; 2015 Aug; 33(33):4117-23. PubMed ID: 26187257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
    Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
    Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of Pertussis Antibody Levels (Anti-PT IgG-Anti-FHA IgG) and Associated Factors in Maternal and Cord Blood].
    Erik HE; Fadıloğlu E; Hasçelik AG; Akın L
    Mikrobiyol Bul; 2023 Apr; 57(2):171-187. PubMed ID: 37067204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants.
    Knuutila A; Barkoff AM; Ivaska L; Tenhu E; Teräsjärvi J; van Gageldonk P; Buisman A; Mertsola J; He Q;
    Emerg Microbes Infect; 2023 Dec; 12(1):2204146. PubMed ID: 37060181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Prepregnancy Pertussis Vaccination in Young Infants.
    Maertens K; Tran TMP; Hens N; Van Damme P; Leuridan E
    J Infect Dis; 2017 Jun; 215(12):1855-1861. PubMed ID: 28863468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.
    Annunziato PW; Rothstein EP; Bernstein HH; Blatter MM; Reisinger KS; Pichichero ME
    Arch Pediatr Adolesc Med; 1994 May; 148(5):503-7. PubMed ID: 8180641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women.
    Villarreal Pérez JZ; Ramírez Aranda JM; de la O Cavazos M; Zamudio Osuna MJ; Perales Dávila J; Ballesteros Elizondo MR; Gómez Meza MV; García Elizondo FJ; Rodríguez González AM
    Hum Vaccin Immunother; 2017 Jan; 13(1):128-135. PubMed ID: 27686182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis.
    Eberhardt CS; Blanchard-Rohner G; Lemaître B; Boukrid M; Combescure C; Othenin-Girard V; Chilin A; Petre J; de Tejada BM; Siegrist CA
    Clin Infect Dis; 2016 Apr; 62(7):829-836. PubMed ID: 26797213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
    Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
    JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses in infants whose mothers received Tdap vaccine during pregnancy.
    Hardy-Fairbanks AJ; Pan SJ; Decker MD; Johnson DR; Greenberg DP; Kirkland KB; Talbot EA; Bernstein HH
    Pediatr Infect Dis J; 2013 Nov; 32(11):1257-60. PubMed ID: 23799518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine.
    Pichichero ME; Green JL; Francis AB; Marsocci SM; Murphy AM; Buscarino C
    Scand J Infect Dis; 1996; 28(2):159-63. PubMed ID: 8792483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.
    Slack MH; Schapira D; Thwaites RJ; Schapira C; Bamber J; Burrage M; Southern J; Andrews N; Miller E
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F57-60. PubMed ID: 14711858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Pertussis Antibodies in Maternal Blood, Cord Serum, and Infants From Mothers With and Those Without Tdap Booster Vaccination During Pregnancy in Argentina.
    Fallo AA; Neyro SE; Manonelles GV; Lara C; Hozbor D; Zintgraff J; Mazzeo S; Davison HE; González S; Zapulla E; Canle O; Huespe M; Galas M; López EL
    J Pediatric Infect Dis Soc; 2018 Feb; 7(1):11-17. PubMed ID: 28040688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn.
    Vilajeliu A; Goncé A; López M; Costa J; Rocamora L; Ríos J; Teixidó I; Bayas JM;
    Vaccine; 2015 Feb; 33(8):1056-62. PubMed ID: 25573035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
    Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
    Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.